Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Terazosin And Metabolic Engagement in Parkinson's Disease
NCT07288450Phase 2Withdrawn
- Start
- Sep 2026
- Primary completion
- Sep 2030
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of terazosin in Parkinson's disease (PD). Planned start Sep 2026; status: withdrawn.
02
Drugs
terazosin
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07288450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288450.